Trial · NCT03197935
Adverse events298
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 298
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anaemia | Blood and lymphatic system disorders | Placebo and Chemotherapy | 65 | 167 | 80 |
| other | Anaemia | Blood and lymphatic system disorders | Atezolizumab and Chemotherapy | 64 | 164 | 89 |
| other | Leukopenia | Blood and lymphatic system disorders | Placebo and Chemotherapy | 17 | 167 | 29 |
| other | Leukopenia | Blood and lymphatic system disorders | Atezolizumab and Chemotherapy | 23 | 164 | 46 |
| other | Neutropenia | Blood and lymphatic system disorders | Placebo and Chemotherapy | 59 | 167 | 123 |
| other | Neutropenia | Blood and lymphatic system disorders | Atezolizumab and Chemotherapy | 65 | 164 | 141 |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Placebo and Chemotherapy | 5 | 167 | 6 |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Atezolizumab and Chemotherapy | 13 | 164 | 16 |
| other | Hypothyroidism | Endocrine disorders | Placebo and Chemotherapy | 0 | 167 | 0 |
| other | Hypothyroidism | Endocrine disorders | Atezolizumab and Chemotherapy | 22 | 164 | 22 |
| other | Dry eye | Eye disorders | Placebo and Chemotherapy | 6 | 167 | 6 |
| other | Dry eye | Eye disorders | Atezolizumab and Chemotherapy | 13 | 164 | 13 |
| other | Lacrimation increased | Eye disorders | Placebo and Chemotherapy | 18 | 167 | 18 |
| other | Lacrimation increased | Eye disorders | Atezolizumab and Chemotherapy | 18 | 164 | 21 |
| other | Vision blurred | Eye disorders | Placebo and Chemotherapy | 11 | 167 | 12 |
| other | Vision blurred | Eye disorders | Atezolizumab and Chemotherapy | 16 | 164 | 16 |
| other | Abdominal pain | Gastrointestinal disorders | Placebo and Chemotherapy | 16 | 167 | 21 |
| other | Abdominal pain | Gastrointestinal disorders | Atezolizumab and Chemotherapy | 23 | 164 | 29 |
| other | Abdominal pain upper | Gastrointestinal disorders | Placebo and Chemotherapy | 13 | 167 | 16 |
| other | Abdominal pain upper | Gastrointestinal disorders | Atezolizumab and Chemotherapy | 21 | 164 | 23 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03197935/events